US FDA Approves Novartis’ New Kidney Disease Drug, Fabhalta News US FDA Approves Novartis’ New Kidney Disease Drug, Fabhalta wbstadmin August 8, 2024 US FDA Approves Novartis’ Fabhalta for IgA Nephropathy, Showing 44% Reduction in Urine Protein Levels. Read More Read more about US FDA Approves Novartis’ New Kidney Disease Drug, Fabhalta
FDA Approves Shield Blood Test for Colon Cancer Screening News FDA Approves Shield Blood Test for Colon Cancer Screening wbstadmin July 29, 2024 The FDA's approval of the Shield blood test gives a new screening option for the colon cancer,... Read More Read more about FDA Approves Shield Blood Test for Colon Cancer Screening
